AwesomeCapital
Search This Blog
Friday, October 4, 2019
Tandem Diabetes upped to Buy from Neutral by UBS
Target $75
https://www.benzinga.com/stock/TNDM/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.